These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 2905775)

  • 1. A quantitative morphological assessment of the effect of lidoflazine and deferoxamine therapy on global brain ischaemia.
    Kumar K; White BC; Krause GS; Indrieri RJ; Evans AT; Hoehner TJ; Garritano AM; Koestner A
    Neurol Res; 1988 Sep; 10(3):136-40. PubMed ID: 2905775
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effect of carbon dioxide, lidoflazine and deferoxamine upon long term survival following cardiorespiratory arrest in rats.
    Badylak SF; Babbs CF
    Resuscitation; 1986 Apr; 13(3):165-73. PubMed ID: 3012732
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inability of flunarizine, lidoflazine or magnesium to counteract delayed hypoperfusion after forebrain ischaemia in the rat.
    Grøgaard B; Gerdin B; Arfors KE
    Acta Neurochir (Wien); 1988; 95(3-4):136-42. PubMed ID: 3228003
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cerebral ischemia and reperfusion: prevention of brain mitochondrial injury by lidoflazine.
    Rosenthal RE; Hamud F; Fiskum G; Varghese PJ; Sharpe S
    J Cereb Blood Flow Metab; 1987 Dec; 7(6):752-8. PubMed ID: 3693430
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Early amelioration of neurologic deficit by lidoflazine after fifteen minutes of cardiopulmonary arrest in dogs.
    Winegar CP; Henderson O; White BC; Jackson RE; O'Hara T; Krause GS; Vigor DN; Kontry R; Wilson W; Shelby-Lane C
    Ann Emerg Med; 1983 Aug; 12(8):471-7. PubMed ID: 6881642
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Amelioration of brain damage by lidoflazine after prolonged ventricular fibrillation cardiac arrest in dogs.
    Vaagenes P; Cantadore R; Safar P; Moossy J; Rao G; Diven W; Alexander H; Stezoski W
    Crit Care Med; 1984 Oct; 12(10):846-55. PubMed ID: 6488823
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Calcium blockers in cerebral resuscitation.
    White BC; Winegar CD; Wilson RF; Krause GS
    J Trauma; 1983 Sep; 23(9):788-94. PubMed ID: 6620432
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pretreatment with lidoflazine, a calcium-channel blocker. Useful adjunct to heterogeneous cold potassium cardioplegia.
    Kates RA; Dorsey LM; Kaplan JA; Hatcher CR; Guyton RA
    J Thorac Cardiovasc Surg; 1983 Feb; 85(2):278-86. PubMed ID: 6823146
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Post resuscitation iron delocalization and malondialdehyde production in the brain following prolonged cardiac arrest.
    Nayini NR; White BC; Aust SD; Huang RR; Indrieri RJ; Evans AT; Bialek H; Jacobs WA; Komara J
    J Free Radic Biol Med; 1985; 1(2):111-6. PubMed ID: 3836237
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of flunarizine on global brain ischemia in the dog: a quantitative morphologic assessment.
    Kumar K; Krause G; Koestner A; Hoehner T; White B
    Exp Neurol; 1987 Jul; 97(1):115-27. PubMed ID: 3582557
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Systemic administration of Zn2+ during the reperfusion phase of transient cerebral ischaemia protects rat hippocampus against iron-catalysed postischaemic injury.
    Helal GK
    Clin Exp Pharmacol Physiol; 2008 Jul; 35(7):775-81. PubMed ID: 18215188
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Myocardial protection by lidoflazine during one-hour normothermic global ischemia.
    Daenen W; Flameng W
    Angiology; 1981 Aug; 32(8):543-51. PubMed ID: 7258731
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A randomized clinical study of a calcium-entry blocker (lidoflazine) in the treatment of comatose survivors of cardiac arrest.
    Brain Resuscitation Clinical Trial II Study Group
    N Engl J Med; 1991 May; 324(18):1225-31. PubMed ID: 2014035
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lidoflazine in the early stages of acute myocardial ischaemia.
    Coker SJ; Fagbemi O; Parratt JR
    Br J Pharmacol; 1982 Jun; 76(2):347-54. PubMed ID: 7093589
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reduction by lifarizine of the neuronal damage induced by cerebral ischaemia in rodents.
    Alps BJ; Calder C; Wilson AD; McBean DE; Armstrong JM
    Br J Pharmacol; 1995 Aug; 115(8):1439-46. PubMed ID: 8564203
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cerebral protective effect of flunarizine in a canine model of cerebral ischaemia.
    Abiko H; Mizoi K; Suzuki J; Oba M; Yoshimoto T
    Neurol Res; 1988 Sep; 10(3):145-50. PubMed ID: 2905777
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparative protective effects of nicardipine, flunarizine, lidoflazine and nimodipine against ischaemic injury in the hippocampus of the Mongolian gerbil.
    Alps BJ; Calder C; Hass WK; Wilson AD
    Br J Pharmacol; 1988 Apr; 93(4):877-83. PubMed ID: 3390655
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Parallel antioxidant and antiexcitotoxic therapy improves outcome after incomplete global cerebral ischemia in dogs.
    Davis S; Helfaer MA; Traystman RJ; Hurn PD
    Stroke; 1997 Jan; 28(1):198-204; discussion 204-5. PubMed ID: 8996512
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Asphyxiation versus ventricular fibrillation cardiac arrest in dogs. Differences in cerebral resuscitation effects--a preliminary study.
    Vaagenes P; Safar P; Moossy J; Rao G; Diven W; Ravi C; Arfors K
    Resuscitation; 1997 Aug; 35(1):41-52. PubMed ID: 9259060
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cardioprotective effects of lidoflazine during 1-hour normothermic global ischemia.
    Flameng W; Daenen W; Borgers M; Thone F; Xhonneux R; van de Water A; van Belle H
    Circulation; 1981 Oct; 64(4):796-807. PubMed ID: 7273379
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.